학술논문
사건판결에서 나타난 미국 연방 대법원의 판결 경향
이용수 160
- 영문명
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.
- 발행기관
- 세창출판사
- 저자명
- 이정아(Jung Ah Lee) 배대헌(Daeheon Bae)
- 간행물 정보
- 『창작과 권리』2012년 가을호 (제68호), 71~110쪽, 전체 39쪽
- 주제분류
- 법학 > 법학
- 파일형태
- 발행일자
- 2012.09.01
7,480원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

국문 초록
영문 초록
This paper analyzes the recent United States Supreme Court's decision, Mayo Collaboraive Service v. Prometheus Laboratories, Inc. This decision reversed the United States Court of Appeals for the Federal Circuit's holding that the claims were patentable because they satisfied the machine-or-transformation test.
In Mayo, the United States Supreme Court held that Prometheus' process was not patent-eligible. Since Prometheus' claims recited the laws of nature -the relationships between concentrations of certain metabolites in the blood and the likelihood that a thiopurine drug dosage would prove ineffective or cause harm- the claimed processes were not patentable. To be patent-eligible, there should be additional features that provide practical assurance that the processes are genuine applications of those laws rather than drafting efforts designed to monopolize the correlations. The three additional steps in the claimed processes were not themselves natural laws but neither were they sufficient to transform the nature of the claims. However, how much of application is necessary to satisfy the patent requirement is still questionable.
After Mayo, the Court remanded two cases -Association of Molecular v. Myriad, and Ultramercial v. Hulu.- to the United States Court of Appeals for the Federal Circuit. This suggests that the Supreme Court intends Mayo to have a wide-ranging impact in biotech and software cases. In light of Mayo, it is unlikely that the Court will hold Myriad and Ultramercial's claims are patent-eligible based on the Court's precedents.
목차
Ⅰ. 머리말
Ⅱ. Mayo Collective Services v. Prometheus Laboratories Inc.(2012)
Ⅲ. Mayo 사건판결 이전의 미국 연방 대법원의 특허법 제101조 해석
Ⅳ. Mayo 사건판결의 영향 - The Association for Molecular Pathology v. USPTO 와 Ultramercial v. Hulu
Ⅴ. 결어
참고문헌
Abstract
해당간행물 수록 논문
참고문헌
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
